ATE449165T1 - Multipotente blutstammzellen aus der nabelschnur und zellbehandlungsmittel damit zur behandlung der ischämischen krankheit - Google Patents

Multipotente blutstammzellen aus der nabelschnur und zellbehandlungsmittel damit zur behandlung der ischämischen krankheit

Info

Publication number
ATE449165T1
ATE449165T1 AT05776026T AT05776026T ATE449165T1 AT E449165 T1 ATE449165 T1 AT E449165T1 AT 05776026 T AT05776026 T AT 05776026T AT 05776026 T AT05776026 T AT 05776026T AT E449165 T1 ATE449165 T1 AT E449165T1
Authority
AT
Austria
Prior art keywords
stem cells
treatment
multipotent stem
umbile
cord
Prior art date
Application number
AT05776026T
Other languages
English (en)
Inventor
Kyung Sun Kang
Original Assignee
Seoul Nat Univ Ind Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seoul Nat Univ Ind Foundation filed Critical Seoul Nat Univ Ind Foundation
Application granted granted Critical
Publication of ATE449165T1 publication Critical patent/ATE449165T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT05776026T 2005-08-26 2005-08-26 Multipotente blutstammzellen aus der nabelschnur und zellbehandlungsmittel damit zur behandlung der ischämischen krankheit ATE449165T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2005/002834 WO2007024036A1 (en) 2005-08-26 2005-08-26 Multipotent stem cells isolated from umbilical cord blood and the cellular therapeutic agent comprisin the same for treating ischemic disease

Publications (1)

Publication Number Publication Date
ATE449165T1 true ATE449165T1 (de) 2009-12-15

Family

ID=37771760

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05776026T ATE449165T1 (de) 2005-08-26 2005-08-26 Multipotente blutstammzellen aus der nabelschnur und zellbehandlungsmittel damit zur behandlung der ischämischen krankheit

Country Status (7)

Country Link
US (1) US20070110727A1 (de)
EP (1) EP1807509B1 (de)
JP (1) JP2007528229A (de)
AT (1) ATE449165T1 (de)
DE (1) DE602005017812D1 (de)
ES (1) ES2336230T3 (de)
WO (1) WO2007024036A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10281478B2 (en) * 2000-04-06 2019-05-07 Wayne P. Franco Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
KR100697326B1 (ko) * 2005-12-02 2007-03-20 재단법인서울대학교산학협력재단 Ｏｃｔ４ 발현능을 가지는 제대혈 유래 다분화능 성체줄기세포 및 그의 제조방법
WO2010027195A2 (ko) * 2008-09-05 2010-03-11 Lee Sung Min 녹용유래세포 및 이의 배양방법
US8796315B2 (en) 2009-06-25 2014-08-05 Darlene E. McCord Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
WO2011088365A1 (en) * 2010-01-14 2011-07-21 Organogenesis, Inc. Bioengineered tissue constructs and methods for producing and using thereof
US8940294B2 (en) 2012-03-02 2015-01-27 Tissuetech, Inc. Methods of isolating and culturing stem cells
EP2925307B1 (de) 2012-11-30 2020-10-28 McCord, Darlene E. Hydroxytyrosol- und oleuropeinzusammensetzungen zur induktion von dna-schäden, zelltod und lsd1-hemmung
TWI825446B (zh) * 2020-08-14 2023-12-11 中國醫藥大學 醫藥組合物治療組織缺血狀況之用途
CN118406645A (zh) * 2024-05-22 2024-07-30 广东龄值生物科技有限公司 一种脐血多功能干细胞的制备方法及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7560280B2 (en) * 2000-11-03 2009-07-14 Kourion Therapeutics Gmbh Human cord blood derived unrestricted somatic stem cells (USSC)
AU2003216286B2 (en) * 2002-02-13 2008-08-28 Celularity Inc. Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
WO2003070922A1 (en) * 2002-02-19 2003-08-28 Medipost Co., Ltd. Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
US20040203142A1 (en) * 2003-04-14 2004-10-14 Reliance Life Sciences Pvt. Ltd. Growth of neural precursor cells using umbilical cord blood serum and a process for the preparation thereof for therapeutic purposes
DE10330216A1 (de) * 2003-07-03 2005-01-20 Jensen, Arne Wilhelm Oluf, Prof. Dr. Verwendung von Stammzellen aus Nabelschnurblut zur Verhinderung von Hirnschäden infolge Sauerstoffmangel und zur Neuroprotektion
KR100560340B1 (ko) * 2003-11-11 2006-03-14 한훈 제대혈로부터 중간엽 줄기세포의 분리 및 배양 방법
US7816137B2 (en) * 2004-01-30 2010-10-19 Lifecord Inc. Method for isolating and culturing multipotent progenitor cells from umbilical cord blood
KR100697326B1 (ko) * 2005-12-02 2007-03-20 재단법인서울대학교산학협력재단 Ｏｃｔ４ 발현능을 가지는 제대혈 유래 다분화능 성체줄기세포 및 그의 제조방법

Also Published As

Publication number Publication date
EP1807509B1 (de) 2009-11-18
EP1807509A4 (de) 2008-08-20
EP1807509A1 (de) 2007-07-18
ES2336230T3 (es) 2010-04-09
US20070110727A1 (en) 2007-05-17
JP2007528229A (ja) 2007-10-11
WO2007024036A1 (en) 2007-03-01
DE602005017812D1 (de) 2009-12-31

Similar Documents

Publication Publication Date Title
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
WO2007024441A3 (en) Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof
EA201100441A1 (ru) Соединения для коррекции уровня мочевой кислоты и способы их применения
EA201000897A1 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
WO2007087367A3 (en) Methods and compositions for modulating the mobilization of stem cells
EA200870019A1 (ru) Лактамовые соединения и способы их применения
EA200600076A1 (ru) Композиции и способы увеличения активности теломеразы
EA200971053A1 (ru) Способы лечения кожных язв
ATE539145T1 (de) Verfahren zum erhalt von mesenchymalen stammzellen
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
IS7925A (is) Hýdroxýetýlamínafleiður til að meðhöndla Alzheimers-sjúkdóm
DE602006007093D1 (de) Kombinationstherapie zur Behandlung von Diabetes und dadurch bedingten Leiden sowie zur Behandlung von mittels Erhöhung des GLP-1-Spiegels im Blut verbesserten Leiden
MX2007004551A (es) Compuestos tiadiazol y metodos de uso.
ATE506951T1 (de) Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit
ATE492542T1 (de) Herstellung und anwendung von biphenyl-4-yl- carbonylaminosäurederivaten zur behandlung von obesitas
ATE521608T1 (de) Glucokinaseaktivatoren
MX2025010350A (es) Composiciones y metodos para aumentar la hemoglobina fetal y tratar la anemia de celulas falciformes
Yang et al. Platelet-rich plasma protects rat chondrocytes from interleukin-1β-induced apoptosis
ATE449165T1 (de) Multipotente blutstammzellen aus der nabelschnur und zellbehandlungsmittel damit zur behandlung der ischämischen krankheit
ATE385807T1 (de) Pharmazeutische verbindung und methoden zur behandlung von menschlichen karzinomen mittels arginin entzug
MA28241A1 (fr) Derives d'indole hydroxyethylamine tricycliques et leur utilisation dans le traitement de la maladie d'alzheimer
Lei et al. Sirtuins as potential targets for neuroprotection: mechanisms of early brain injury induced by subarachnoid hemorrhage
WO2006091895A3 (en) Method for the treatment of retinopathy of prematurity and related retinopathic diseases
EA201170647A1 (ru) Пептиды-агонисты crhr2 и их использование
JP2016510808A5 (de)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties